[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612174":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":38,"collaborators":10,"id":40,"slug":10,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":10,"enrollmentInfo":47,"targetDuration":50,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MI group",null,"Patients who present with myocardial infarction and undergo successful percutaneous coronary intervention will be eligible for enrollment.",[13],"Procedure: Percutaneous coronary intervention",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":10},"PROCEDURE","Percutaneous coronary intervention",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Jun Jiang, MD","CONTACT","+86 15657125311","21918219@zju.edu.cn",[26],{"facility":27,"status":10,"city":28,"state":29,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":10},"The Second Affiliated Hospital of Zhejiang University School of Medicine","Hangzhou","Zhejiang","310009","China",{"type":33,"coordinates":34},"Point",[35,36],120.16142,30.29365,{"lat":36,"lon":35},{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100612174",false,"NCT07250152","Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction","Inclusion Criteria:\n\n1. Age ≥18 years old\n2. Presented with myocardial infarction, including NSTEMI and STEMI\n3. Undergoing successful percutaneous coronary intervention.\n\nExclusion Criteria:\n\n1. Subjects who decline protocol-mandated follow-up or withhold informed consent.\n2. Individuals whose expected survival is \\\u003C 1 year.","ALL","18 Years",{"count":48,"type":49},1544,"ESTIMATED","60 Months","OBSERVATIONAL","Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.",[54],"Myocardial Infarction (MI)",[56],"myocardial infarction","NOT_YET_RECRUITING","2025-11-18",{"date":60,"type":61},"2025-11-26","ACTUAL",{"date":63,"type":49},"2025-12-01",{"date":65,"type":49},"2028-12-31",{"name":5,"class":6},1]